Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Seaman

Showing results (1-10 of 334) with videos related to

Pageof 34
Sort By:
Current Opinion in HIV and AIDS|May 30, 2023
Divide and conquer: broadly neutralizing antibody combinations for improved HIV-1 viral coverageKshitij Wagh, Michael S Seaman
Frontiers in Immunology|August 6, 2021
Broadly Neutralizing Antibodies for HIV-1 PreventionStephen R Walsh, Michael S Seaman
Current Opinion in HIV and AIDS|December 22, 2017
Neutralization tiers of HIV-1David C Montefiori, Mario Roederer, Lynn Morris, et al.
Journal of Virology|March 8, 2019
A Highly Unusual V1 Region of Env in an Elite Controller of HIV InfectionZachary A Silver, Gordon M Dickinson, Michael S Seaman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2012
Enhanced HIV-1 neutralization by antibody heteroligationHugo Mouquet, Malte Warncke, Johannes F Scheid, et al.
Nature Biotechnology|October 8, 2013
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activityRuijiang Song, Deena A Oren, David Franco, et al.
Cell|June 18, 2016
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and PotencyStylianos Bournazos, Anna Gazumyan, Michael S Seaman, et al.
Journal of the American Chemical Society|May 14, 2025
Specific Interactions between HIV-1 Env Cytoplasmic Tail and Gag Matrix Domain Probed by NMRManish Chaubey, Hailong Gao, Christy L Lavine, et al.
Cell|September 13, 2014
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activityStylianos Bournazos, Florian Klein, John Pietzsch, et al.
Journal of Virology|March 12, 2010
Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityJohn Pietzsch, Johannes F Scheid, Hugo Mouquet, et al.
Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:
Pageof 34
Current Opinion in HIV and AIDS|May 30, 2023
Divide and conquer: broadly neutralizing antibody combinations for improved HIV-1 viral coverageKshitij Wagh, Michael S Seaman
Frontiers in Immunology|August 6, 2021
Broadly Neutralizing Antibodies for HIV-1 PreventionStephen R Walsh, Michael S Seaman
Current Opinion in HIV and AIDS|December 22, 2017
Neutralization tiers of HIV-1David C Montefiori, Mario Roederer, Lynn Morris, et al.
Journal of Virology|March 8, 2019
A Highly Unusual V1 Region of Env in an Elite Controller of HIV InfectionZachary A Silver, Gordon M Dickinson, Michael S Seaman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2012
Enhanced HIV-1 neutralization by antibody heteroligationHugo Mouquet, Malte Warncke, Johannes F Scheid, et al.
Nature Biotechnology|October 8, 2013
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activityRuijiang Song, Deena A Oren, David Franco, et al.
Cell|June 18, 2016
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and PotencyStylianos Bournazos, Anna Gazumyan, Michael S Seaman, et al.
Journal of the American Chemical Society|May 14, 2025
Specific Interactions between HIV-1 Env Cytoplasmic Tail and Gag Matrix Domain Probed by NMRManish Chaubey, Hailong Gao, Christy L Lavine, et al.
Cell|September 13, 2014
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activityStylianos Bournazos, Florian Klein, John Pietzsch, et al.
Journal of Virology|March 12, 2010
Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityJohn Pietzsch, Johannes F Scheid, Hugo Mouquet, et al.
Pageof 34